Transdifferentiation (TD) is the direct reprogramming of adult cells into cells of alternate fate and function. We have previously shown that liver cells can be transdifferentiated into beta-like, insulin-producing cells through ectopic expression of pancreatic transcription factors (pTFs). However, the efficiency of the process was consistently limited to <15% of the human liver cells treated in culture. The data in the current study suggest that liver-to-pancreas TD is restricted to a specific population of liver cells that is predisposed to undergo reprogramming. We isolated TD-predisposed subpopulation of liver cells from >15 human donors using a lineage tracing system based on the Wnt response element, part of the pericentral-specific promoter of glutamine synthetase. The cells, that were propagated separately, consistently exhibited efficient fate switch and insulin production and secretion in >60% of the cells upon pTF expression. The rest of the cells, which originated from 85% of the culture, resisted TD. Both populations expressed the ectopic pTFs with similar efficiencies, followed by similar repression of hepatic genes. Our data suggest that the TD-predisposed cells originate from a distinct population of liver cells that are enriched for Wnt signaling, which is obligatory for efficient TD. In TD-resistant populations, Wnt induction is insufficient to induce TD. An additional step of chromatin opening enables TD of these cells. Conclusion: Liver-to-pancreas TD occurs in defined predisposed cells. These cells' predisposition is maintained by Wnt signaling that endows the cells with the plasticity needed to alter their transcriptional program and developmental fate when triggered by ectopic pTFs. These results may have clinical implications by drastically increasing the efficacy of TD in future clinical uses. (HEPATOLOGY 2018; 68:1589-1603. C ells' differentiation fate can be reprogrammed by overexpression of selected transcription factors, usually a subset of those required for normal development of the relevant cell type. Recent examples include the conversion of fibroblasts to cardiomyocytes, neurons, and hepatocytes.
C ells' differentiation fate can be reprogrammed by overexpression of selected transcription factors, usually a subset of those required for normal development of the relevant cell type. Recent examples include the conversion of fibroblasts to cardiomyocytes, neurons, and hepatocytes. (1) (2) (3) (4) To date, the limited efficiency of direct reprogramming is a major obstacle for using autologous organs in regenerative medicine (reviewed by Graf (5) ). Ectopic expression of pancreatic transcription factors (pTFs) induces direct reprogramming of adult liver cells into pancreatic-like, glucose-regulated insulin and other pancreatic hormone-producing cells (e.g., insulin-producing cells [IPCs] ). (6) (7) (8) (9) The transdifferentiation (TD) process involves two distinct steps: suppression of the hepatic repertoire in all the pTF-expressing cells (10) and activation of the pancreatic phenotype and function only in <15% of the human liver cells in vitro (7, 9, 11) and in <0.5% of rodent liver cells in vivo. (6, 8) In vivo, in mice, TD into pancreatic-like cells is generally restricted to a small group of cells located around the central veins, (6, 8, 12) although additional populations of liver cells were suggested to undergo the process. (13, 14) Liver cells display a remarkable phenomenon of functional heterogeneity, or metabolic zonation, (15) (16) (17) related to the cells' proximity to the central and portal veins (pericentral and periportal cells, respectively). A major role for the canonical Wnt/b-catenin signaling pathway has been demonstrated in mediating this functional heterogeneity. (15, 16, 18) In the normal adult liver, Wnt/b-catenin signaling is primarily active in pericentral hepatocytes. (19) In the mouse and rat, Wnt signaling is instrumental in liver repopulation following injury or partial hepatoctomy. (20) (21) (22) Similarly, Wnt signaling is responsible for maintenance of a self-renewing niche of pericentral liver cells that can differentiate into and replace approximately 40% of the hepatocytes along the liver lobule during homeostatic renewal in mice. (23) The Wnt family of glycoproteins signals at the cell surface via at least two receptors: Frizzled (FZD) and lipoprotein-related protein receptor (LRP). A key transducer of canonical Wnt signaling is b-catenin. Following binding of Wnt proteins to their receptors, b-catenin translocates into the nucleus, where it forms a complex with DNA-binding transcription factors to activate the expression of target genes. (24, 25) The findings of the present study suggest that the heterogeneity in Wnt signaling, which is observed in the intact liver, persists in proliferating adult human liver cells in culture; and accounts for differences in these cells' propensity to undergo pTF-induced reprogramming into IPCs. Human liver cells, isolated by their capacity to activate a Wnt response element (WRE) of the pericentral glutamate ammonia ligase (GLUL) promoter, demonstrate persistent and heritable reprogramming propensity. Cultures derived from multiple human donors constitute 4%-15% of these TD-prone cells. Moreover, Wnt pathway activity is positively correlated with the efficiency of reprogramming of these cells. By contrast, restoration of Wnt signaling is insufficient to endow recalcitrant cells with reprogramming capacity, unless it is supplemented with chromatin manipulation by histone deacetylases inhibitors.
In summary, this study suggests that the reprogramming capacity of liver cells is an inherent characteristic, which depends on continuous Wnt activity that endows them with the (epigenetic) plasticity needed for a change in their terminal fate.
Materials and Methods

HUMAN LIVER TISSUES AND CULTURES
Liver tissues were used with the approval of the Sheba Medical Center Committee on Clinical Investigations (the institutional review board). Detailed clinical information of the donors is presented in Supporting Table S1 . Tissue processing, isolation and maintenance of cell cultures were described previously. (7) 
INDUCTION OF TD IN VITRO
A total of 100,000 cells/well were seeded in a 6-well plate in a low glucose Dulbecco's modified Eagle's medium supplemented with 2 mM L-glutamine, 10% serum, antibiotics, 10 mM nicotinamide, 20 ng/mL epidermal growth factor, and 5 nM exendin-4. The cells were infected with 1000 multiplicity of infection (MOI) Ad-STF (rat Pdx-1) and 250 MOI AdNeuroD1. After 48 hours, the cells were harvested and counted, and 100,000 cells were infected with 50 MOI of Ad-MafA and replated as above. Seventy-two hours later, the cells were analyzed for gene expression and insulin secretion, as detailed below and as described previously. (7) In the separated cultures, TD was induced at identical passages of enhanced green fluorescent protein (eGFP)-positive (eGFP 
ANIMALS
Mice were housed in an air-conditioned environment under a 12-hour light/dark cycle and were handled according to institutional animal welfare regulations (ethics statements 732/12/AMIN and 1023/16/ANIM).
INDUCTION OF TD IN VIVO
BALB/c mice (age, 8-9 weeks; weight, 18-19 g) were administered 5 3 10 10 plaque-forming units of Ad-CMV-Pdx-1 recombinant adenoviruses through systemic injection into the tail vein. (6) Immunohistochemistry (IHC) analyses of insulin and GLUL-positive cells was performed on posttreatment day 5 as described previously (6) and using anti-GLUL monoclonal antibody (BD Bioscience, San Jose, CA, 1;1000), respectively.
IMPLANTATION OF TD LIVER CELLS IN VIVO
SCID-Beige mice (age, 8-9 weeks; weight, 22-25 g) were implanted with 4 3 10 6 TD cells subcutaneously as described previously. (26) Some implants were collected 2 weeks after implantation, fixated, and stained as described above using anti-insulin (Dako, Glostrup, Denmark) and anti-glucagon (Dako) antibodies.
DETERMINATION OF HUMAN SERUM INSULIN SECRETION IN HUMAN CELLS IMPLANTED MICE
Following a 6-hour fast, mice were injected intraperitoneally with glucose in saline at 2 mg/g body weight. Serum was collected 30 minutes later and human C-peptide levels were analyzed as described previously. (9) The Ultrasensitive Human C-Peptide ELISA kit (Mercodia, Uppsala, Sweden) used has 3% cross-reactivity with proinsulin but no cross-reactivity with mouse C-peptide and mouse insulin.
SOLUBLE FACTORS
Wnt3A protein (R&D Systems, Minneapolis, MN) was added at concentrations of 100 ng/mL. DKK (R&D) concentrations are indicated in the text. Sodium butyrate (Merck, Darmstadt, Germany) was added at a concentration of 5 mM. Suberoylanilide hydroxamic acid (Sigma) was added at a concentration of 1 lM.
VIRUSES
Lineage-Tracing Lentiviruses
CMV-loxP-DsRed-loxP-eGFP was described previously. (27) A vector containing glutamate synthetase (GS)/GLUL regulatory element (GSRE) upstream of minimal thymidine kinase promoter (TKp) has been described previously. (28) The GSRE/TKp element was subsequently cloned into an EcoRI/AvaI site upstream of a Cre-recombinase in a pTrip lentiviral expression clone.
Recombinant Adenoviruses
Ad-CMV-pdx1, Ad-CMV-mafA, and Ad-CMVb-Gal have been described previously. (7) Ad-CMVNeuroD1 contains human NEUROD1 complementary DNA sequence. Ad-b-catenin-S37A (S37A) (29) was a gift from Jan K. Kitajewski (Columbia University Medical Center, NY) and was used to infect liver cells at 10 MOI.
In vitro lineage tracing was performed by a modified dual lentivirus system as described previously. (30) Cells derived from >15 different donors (age range, 3-60 years) were treated by both lentiviruses. Between 5% and 15% of the cells became eGFP-positive within 10 days, and sorted by FACSAria, followed by separate seeding and propagation.
INSULIN SECRETION
Glucose-regulated insulin secretion was measured by radioimmunoassay kit (DPC, Los Angeles, CA) as described previously. (7) Secretion under high glucose concentration (17.5 mM) was measured using the Ultrasensitive Insulin ELISA kit (Alpco, Salem, NH) according to the manufacturer's protocol.
ANTIBODIES
IHC was performed as described previously. (7) Polyclonal guinea pig anti-insulin antibody (Dako, catalog #A0564) was used at 1:100 dilution. Polyclonal rabbit anti-glucagon antibody (Dako, catalog #A0565) was used at 1:200 dilution. GS/GLUL expression was detected by monoclonal antibody (1:1000; BD Bioscience). Western blot analysis was performed as described previously. (11) Monoclonal anti-active bcatenin antibody (clone 8E7, specific to serine 37 or threonine 41 dephosphorylation; Millipore, Merck, Darmstadt, Germany) was used at 1:2000 dilution.
GENE EXPRESSION
RNA was prepared from cells and reverse-transcribed. Relative expression of the indicated genes was measured with the StepOne Real-Time PCR System using Fast SYBR Green Master Mix (Thermo Fisher Scientific, Waltham, MA), with b-actin as reference. Amplification primers are detailed in Supporting Table S2 .
GLOBAL GENE EXPRESSION ANALYSIS
Complementary DNA was synthesized, labeled, and hybridized to HG-U133A-2 array (Affymetrix, Santa Clara, CA) containing 22,215 gene transcripts (corresponding to 14,500 well-characterized human genes), washed, and scanned using the HP G2500A GeneArray Scanner (Hewlett Packard, Palo Alto, CA) according to the manufacturer's protocol. Data analysis was performed using Partek Genomics Solution software (www.partek.com). For the raw data normalization, we applied the Robust Multichip Average method. Biological processes enrichment was analyzed using the Panther tool (http://pantherdb.org/). (31, 32) 
STATISTICAL ANALYSES
Statistical analyses were performed using a twosampled Student t test assuming equal variances.
Results
PRIMARY CULTURES OF HUMAN LIVER CELLS ARE CONSISTENTLY SEPARATED IN VITRO INTO TWO DISCRETE GROUPS
We demonstrated previously that a combination of pTFs and soluble factors activates the pancreatic lineage in approximately 10%-15% of treated liver cells. (7, 11) In pTF-treated mouse livers, despite uniform distribution of ectopic PDX1 expression, induced IPCs were primarily localized to GLUL-expressing, pericentral hepatic cells (6, 8, 12) (Fig. 1 ), potentially suggesting that pericentral hepatic cells may have a predisposition for TD into pancreatic-like cells. This led us to look for a possible association between TD competence and cells' lineage in human livers as well. A lentivirus-based lineage tracing approach was used to isolate human liver cells that are capable of activating part of the GLUL promoter in vitro. The system is based on a CMV-loxP-DsRed-loxPeGFP (R/G) reporter and Cre-recombinase under the control of the pericentral specific GSRE that contains WRE ( Fig. 2A, left) . In primary cultures derived from 15 different human donors, typically 5%-15% of the cells were GS/eGFP 1 , whereas most of the cells retained DsRed expression (Fig. 2Ai-iii) . Both populations had similar rates of proliferation after separation (Supporting Fig. S1 ). Differential expression of Wnt pathway genes was preserved, as confirmed by higher levels of active bcatenin protein in eGFP 1 cells (Fig. 2B ,C) whereas transcript levels of the Wnt inhibitor gene APC were 6-fold higher in DsRed 1 cells (Fig. 2D ). These differential characteristics were maintained with an increase in culture passage and after cryopreservation, suggesting that primary human liver cells, while undergoing Epithelial-Mesenchymal Transition (EMT) in culture, maintain a unique Wnt-signaling pattern and can be separated into two subpopulations of cells with consistent characteristics.
WNT RESPONSIVE CELLS POSSESS AN INNATE PROPENSITY FOR REPROGRAMMING INTO ENDOCRINE PANCREAS
Both eGFP 1 and DsRed 1 cultures were treated similarly with pTFs and analyzed for the activation of the pancreatic lineage at the molecular, cellular, and functional levels. eGFP 1 cells displayed higher levels of endogenous pancreatic gene expression patterns (Fig. 3A) and glucose-dependent insulin secretion (Fig. 3B) . The differential expression of the pancreatic hormones occurred despite equivalent expression of ectopic pTFs (rat-PDX1) and similar rates of cell proliferation of both eGFP 1 and DsRed 1 cultures (Supporting Fig. S1 ). IHC revealed that 64.1% 6 7.9% of the cells stained positive for insulin (Fig. 3C ) compared with 10%-14% of cells in unseparated cultures. (7, 11) The difference in the efficiency of reprogramming was heritable and persisted after extended cell propagation in culture (Fig. 3D) . The longlasting functional superiority of the TD-eGFP 1 over TD-DsRed 1 was exhibited further upon in vivo implantation in immune-deficient mice (Fig. 3E,F) . TD-eGFP 1 cells consistently secreted more processed human insulin (c-peptide) into the bloodstream compared with similar numbers of TD-DsRed 1 cells over 8 weeks of follow-up (Fig. 3E) . Explants excised from implanted mice 2 weeks after implantation suggest a more robust hormones production in eGFP 1 cells compared with explants of DsRed 1 implanted mice (Fig. 3F) . eGFP 1 cells'-explants contain many more IPCs (green), glucagon-producing cells (red), and bihormonal-containing cells (orange) than DsRed These data demonstrate that TD propensity consistently correlates with a small specific population of cells in the human liver. TD is characterized by two distinct developmental processes, both of which are induced by the expression of ectopic pTFs (10) : repression of the hepatic repertoire of genes and activation of the alternate pancreatic set of genes. Whereas hepatic gene repression occurs in each of the Pdx-1-expressing cells, activation of the pancreatic genes is restricted to a subset of liver cells, both in vivo (6, 8) and in vitro (10) in mice and humans, respectively. Hepatic dedifferentiation is obligatory but is insufficient for the activation of the alternate pancreatic function by ectopic pTFs. (10) The contrast between the uniform repression of the hepatic genes and the limited pancreatic differentiation, brought up to test the hypothesis that TD predisposition lies only in the capacity to activate the pancreatic lineage, rather than in the loss of hepatic fate. In support of our hypothesis, following TD both eGFP 1 and DsRed 1 cells exhibited similar repression of hepatic genes such as ADH and CEBPb (Fig. 4) .
These data suggest that the discriminating factor between the two populations of cells lies in their differential capacity to activate the pancreatic repertoire.
PREDISPOSITION IS ASSOCIATED WITH DISTINCT SIGNALING PATHWAYS ALTERATIONS UPON REPROGRAMMING
In order to test whether inherent molecular characteristics are associated with the ability to transdifferentiate, we looked into the global gene expression profiles of both populations by microarrays. A total of 394 genes were differentially expressed between the two populations (P < 0.05), a large portion of which was associated with metabolic processes and responses to stimuli as well as developmental processes (Fig. 5A ).
After reprogramming, 1737 genes were altered in eGFP 1 cells and 2775 were altered in DsRed 1 cells (P 0.05). Of these, only 564 genes were common. In order to analyze the biological significance, we used published overrepresentation analysis (31, 32) and found that distinct biological functions are enriched by genes that are altered upon reprogramming in each population. Changes in differentiation and developmental processes are unique to the predisposed population. By contrast, genes that were altered in DsRed 1 cells did not enrich any biological processes that we could associate with differentiation or reprogramming (Fig. 5B) . These results suggest that the ability of eGFP 1 cells to turn on specific developmental pathways may govern their predisposition to transdifferentiate into IPCs.
During normal development, expression of mutually exclusive Wnt pathway genes specifies liver/pancreas development from common progenitors. (33) Because microarray analyses indicated that most of the genetic alterations upon pTF treatment are populationspecific, we tested whether the same applies to Wnt pathway components.
The Wnt receptors ROR2, FZD4, and LRP5 specify pancreatic (ROR2 and FZD4) or hepatic (LRP5) cell fate, respectively, from a common endoderm progenitor. (33) After TD induction, a significant increase in FZD4 and ROR2 transcripts, as well as Wnt1, which has been associated with pancreas development, (34) was exclusive to eGFP 1 cells (Fig. 5C, top) , whereas an increase in transcript levels of the hepatic lineagespecifying LRP5 was ubiquitous (Fig. 5C, bottom) .
Thus, activation of pancreas-specifying Wnt signals is associated with eGFP 1 cells' predisposition for TD.
ACTIVE WNT SIGNALING IS OBLIGATORY FOR ACTIVATION OF PANCREATIC LINEAGE AND FURTHER PROMOTES REPROGRAMMING EFFICIENCY ONLY IN PREDISPOSED HUMAN LIVER CELLS
Based on the major role of the Wnt pathway in liver/ pancreas cell fate acquisition and the presence of WRE in the lineage tracing system, we tested whether liver-topancreas TD is controlled by the Wnt pathway. In unseparated human liver cultures, the addition of exogenous Wnt3A protein during TD resulted in a marked increase in glucose-regulated insulin secretion, whereas insulin secretion was abolished by addition of the competitive Wnt signaling inhibitor DKK (Fig. 6A ). These observations suggest that Wnt signaling plays an obligatory role in pTF-induced liver cell reprogramming.
We next asked whether TD-resistant (DsRed 1 ) cells can be induced to transdifferentiate through activation of Wnt. We activated the Wnt pathway 48 hours before induction of reprogramming at two points along its pathway: 1) stabilizing endogenous b-catenin using lithium (35) and 2) replenishing active b-catenin through ectopic expression of S37A, a constitutively active b-catenin mutant. (29) Consistent with the induction of reprogramming in unseparated cultures by WNT3A, both treatments increased the efficiency of TD in eGFP 1 cells (Fig.  6B,C) . The increase in pancreatic cell fate acquisition appears to be specific toward b-like cells, whereas SST and GCG levels (d and a cells, respectively) remained unaffected. By contrast, DsRed 1 cells were unaffected by Wnt activation with regard to activation of the pancreatic lineage (Fig. 6D,E) , although canonical Wnt targets levels were elevated (data not shown). Moreover, whereas the effect of S37A on eGFP 1 peaked at 10 MOI, increasing the viral load up to 50-fold did not have a significant effect on DsRed 1 cells (Supporting Fig. S2 ). Thus, not only lower levels of b-catenin, but innate molecular characteristics of the DsRed 1 population dictate its inability to undergo efficient reprogramming.
INNATE WNT SIGNALING IS A PREREQUISITE FOR REPROGRAMMING PROPENSITY
We demonstrated that activating Wnt signaling increases the efficiency of reprogramming only in TD-predisposed liver cells without affecting the TD-resistant DsRed 1 population. We next asked whether preexisting active Wnt signaling pathway is a necessary prerequisite for reprogramming predisposition. To do so, we blocked the cell surface Wnt receptor in eGFP 1 cells by DKK for 48 hours before TD. We 1 cells (n 5 3-6). *P < 0.05; **P < 0.005; ***P < 0.0005; N.S., not significant.
FIG. 6. Active Wnt signaling controls the activation of the pancreatic lineage in the liver. (A)
Efficient liver-to-pancreas reprogramming relies on active Wnt signaling. Wnt signaling was activated by WNT3A, or, alternatively, blocked by DKK, concomitantly to ectopic pTF expression (TD) in human liver cultures. Glucose-stimulated insulin secretion was measured 5 days later. Results are expressed as the mean and standard error of 3-6 repeats in three different donors. *P < 0.05; **P < 0.005; ***P < 0.0005. (B,C) Wnt signaling was induced in eGFP 1 cells by lithium (Li) or ectopic expression of constitutively active b-catenin (Ad-S37A). Efficiency of reprogramming was measured by the activation of pancreatic gene expression and relative insulin secretion induced by high glucose concentrations (17.5 mM). *P < 0.05; **P < 0.005. (D,E) activation of Wnt signaling in DsRed 1 cells by either lithium or S37A does not increase reprogramming efficiency. Transcript levels of indicated genes are presented as average and SE of increase above cells treated with pTFs alone, normalized to b-actin levels (n 5 3-4 independent repeats in different donors). removed the DKK and proceeded with pTF treatment in the presence of S37A, which acts downstream of the Wnt receptor (see schematic illustration in Fig. 7A ). S37A should be able to rescue Wnt reprogramming if preliminary Wnt signaling is not required for predisposition.
As was observed earlier, S37A increased the efficiency of reprogramming in the eGFP 1 population. However, when preceded by Wnt signaling inhibition, S37A was unable to enhance the process (Fig. 7B) , turning the eGFP 1 cells into DsRed-like cells by abrogating the predisposition for efficient reprogramming. These data suggest that even a short-term disruption of the innate Wnt signaling induces intracellular alteration that cannot be overcome by b-catenin replenishment.
OPENING CHROMATIN ENABLES DsRed
1 CELLS TO RESPOND TO pTF-INDUCED REPROGRAMMING AND WNT ACTIVATION b-catenin and its downstream DNA-binding proteins recruit chromatin-modifying enzymes, such as histone acetyl transferases and histone deacetylases (HDACs), to target genes, thus enabling or repressing transcription, respectively. (36) (37) (38) (39) (40) It is possible that in the absence of Wnt signaling, repressive chromatin is formed and prevents activation of pancreatic genes in DsRed 1 cells, as well as DKK-pretreated eGFP 1 cells. We therefore tested whether "chromatin opening" would enable induction of reprogramming by Wnt.
We used sodium butyrate, an HDAC inhibitor, to preserve histone hyperacetylation, which is associated with permissive chromatin structure. (40) Strikingly, combining sodium butyrate with Wnt activation resulted in an increase in reprogramming of DsRed 1 cells (Fig. 7C) . Suberoylanilide hydroxamic acid, an additional effective HDAC inhibitor, had a similar effect: its combination with Wnt activation also resulted in an increase in reprogramming of DsRed 1 cells (Fig. 7D) . Similar to the effect of HDAC inhibition on the reprogramming capacity of DsRed 1 cells, sodium butyrate treatment also alleviated the effect of Wnt signaling inhibition of eGFP 1 cells (Supporting Fig. S3 ). Taken together, our observations suggest that permissive chromatin organization and active Wnt signaling are the two requirements that are necessary and sufficient for reprogramming predisposition and capacity of liver cells.
Discussion
Wnt regulates multiple cellular functions, including proliferation and differentiation. In mouse and rat liver, Wnt signaling plays an important role during homeostatic renewal (23) and liver regeneration. (20) (21) (22) In the present study, we describe an additional role for Wnt in the human liver: controlling direct reprogramming into beta-like cells. The active Wnt pathway plays a dual role in reprogramming: 1) enabling reprogramming predisposition to endocrine pancreas and 2) controlling the efficiency of the process in predisposed cells.
In in vitro culture, proliferating human liver cells undergo dedifferentiation and epithelial-tomesenchymal transition. (30) However, our data suggest that these primary cultures of proliferating human liver cells retain, at least partially, the heterogeneity in Wnt signaling, which is in vivo related to the liver zonation.
Adult liver cells that respond to Wnt signaling may not be the only population of cells capable of undergoing pTF-induced TD to endocrine pancreas. Several groups have identified other populations of liver cells capable of acquiring the alternate pancreatic repertoire upon ectopic expression of pTFs in mice in vivo. Banga et al. (13) described TD of SOX9 1 cells into IPCs. Similarly, ectopic expression of NGN3 induced transdetermination in the cells close to the canal of Hering. (14) These cells were suggested to retain pluripotency characteristics. The difference between these findings and ours could be attributed to the fact that our study was performed with human-derived cells in vitro, which may respond differently to the pTFs compared with in vivo cells in mice. The human liver cells described herein originate from adult human liver cells and cannot be considered classical stem cells. Rather, these cells originated from differentiated adult cells with distinct metabolic function that possess developmental plasticity. However, due to the mesenchymal nature of human liver cells that have undergone EMT in vitro, (30) and the technical challenge to trace human-derived cells, we cannot unequivocally suggest that the human liver cells, which are predisposed to TD, indeed originate from adult human pericentral liver cells.
Wnt signaling enhancement further improves the TD efficiency only in TD-prone human liver cells. Several soluble factors have been documented in the past for promoting TD of liver cells, possibly affecting only the TD-prone population of liver cells. We found that GLP-1, a known Wnt activator with insulinotrophic effects, (41) improves the efficiency of liver cell reprogramming by increasing both insulin production per cell and the number of IPCs through direct effect on TD-predisposed cell proliferation. (11) Further studies are needed to unravel a possible cross-talk between the GLP-1 and Wnt pathways in promoting the efficiency of reprogramming of liver cells. Several additional soluble factors, including epidermal growth factor and nicotineamide, which have been found to be instrumental in promoting liver-to-pancreas TD, should be analyzed further in the context of TD propensity of adult human liver cells.
GSRE, upon which the lineage-tracing was based, contains, in addition to WRE, a STAT5 binding site. STAT5 has been found to be unrelated to pancreatic development. (42) However, although the collective data we gathered in this study consistently point toward Wnt being a determinant factor in enabling TD, we cannot exclude a potential role for STAT5 in the efficiency or predisposition for TD.
The pivotal role of active Wnt signaling in liver-topancreas TD is in reciprocal agreement with studies of pancreas-to-liver TD. Wallace et al. (43) suggested that transient suppression of Wnt signaling is pivotal to the glucocorticoid-dependent TD of B13 pancreatic acinar cells to the hepatic lineage. Although Wnt is indispensable for liver-to-pancreas TD, it is insufficient to drive the pTF-induced process alone in TD-resistant liver cells. An additional step of inhibiting HDAC was required to activate reprogramming of the resistant (DsRed 1 ) liver cell population. This suggests that restrictions imposed by repressive chromatin organization may stand behind the inability of active b-catenin (S37A) to activate reprogramming of DsRed 1 cells or restore DKK-treated eGFP 1 cell predisposition. Indeed, DNA-binding proteins downstream of b-catenin recruit chromatin modifying enzymes to target genes. (36) (37) (38) (39) Generally, developmental genes are embedded in silent chromatin, and reprogramming (as well as normal development) requires a pioneer factor with the ability to open the chromatin. (44) We believe that preexisting stable and continuous Wnt activity endows cells with an epigenetic accessibility that shapes their ability to alter the developmental fate, as well as their ability to develop into the entire hepatic repertoire. (23) Wnt-negative cells may have lost their ability to change their fate in response to reprogramming factors, even upon reactivation of Wnt, through 1) preexisting/pTF-induced expression of a (yet unknown) pioneer factor in predisposed but not recalcitrant cells and 2) inherent differences in chromatin organization between both cell populations. Figure 8 shows our model for cell predisposition for TD, in which the liver is heterogeneous with regard to Wnt signaling (19) (top panel). Following separation based on Wnt activity, we suggest that the heterogeneity is maintained, and cells with continuous innate Wnt activity (middle panel, green ovals) possess a permissive epigenetic landscape, endowing these predisposed cells with the ability to express silenced pancreatic genes after introduction of pTFs (bottom panel, green ovals). Conversely, in the absence of Wnt signaling (in DsRed 1 cells and following DKK treatment of eGFP 1 cells) (middle panel, red ovals), repressive epigenetic modifications prevent access to pancreatic differentiation-associated genes. In addition, a "locked" terminal cell fate may occur, which would prevent any subsequent access of pTFs/downstream Wnt signal transducing proteins (bottom panel, red ovals). These characteristics can be changed by epigenetic manipulations allowing Wnt signaling to affect TD.
In conclusion, our study demonstrates how innate molecular characteristics of specific subpopulations of cells enable them to respond to cell-fate alteration stimuli and transdifferentiate toward an alternate fate. It provides a mechanistic explanation to the restricted efficiency of the TD process and suggests modalities to increase it. Finally, the Wnt based enrichment of a predisposed population has clinical implications on increasing the efficacy and reducing the number of cells that are required for implantation, bringing a TDbased approach of regenerative medicine closer to its clinical implementation.
